Atossa Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Atossa Therapeutics, Inc.‘s stocks are currently a part of 64 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 23.26M shares of Atossa Therapeutics, Inc.. Compared to the previous quarter, the number fell by -35.12% or -12.59M shares fewer. As for the holding position changes, 14.06% (9) of current hedge fund investors increased the number of shares held, 42.19% (27) of current holders sold a part of the shares held, and 40.63% (26) closed the holdings completely. 17 hedge funds are new holders of Atossa Therapeutics, Inc. stock in Q2 2022, it is 26.56% of total holders.
Hedge funds holding Atossa Therapeutics (Q3 2017 – Q2 2022)
| Q3 2017 | 10 |
|---|---|
| Q4 2017 | 9 |
| Q1 2018 | 17 |
| Q2 2018 | 9 |
| Q3 2018 | 8 |
| Q4 2018 | 13 |
| Q1 2019 | 9 |
| Q2 2019 | 8 |
| Q3 2019 | 9 |
| Q4 2019 | 10 |
| Q1 2020 | 6 |
| Q2 2020 | 8 |
| Q3 2020 | 20 |
| Q4 2020 | 12 |
| Q1 2021 | 51 |
| Q2 2021 | 85 |
| Q3 2021 | 87 |
| Q4 2021 | 85 |
| Q1 2022 | 74 |
| Q2 2022 | 64 |
Hedge funds changes in Atossa Therapeutics positions (Q3 2017 – Q2 2022)
| Q3 2017 | 4 | 2 | 1 | 3 | 0 |
|---|---|---|---|---|---|
| Q4 2017 | 2 | 2 | 3 | 3 | -1 |
| Q1 2018 | 11 | 3 | 1 | 3 | -1 |
| Q2 2018 | 9 | 0 | 0 | 17 | -17 |
| Q3 2018 | 3 | 1 | 0 | 4 | 0 |
| Q4 2018 | 6 | 3 | 2 | 1 | 1 |
| Q1 2019 | 3 | 3 | 2 | 7 | -6 |
| Q2 2019 | 2 | 2 | 4 | 3 | -3 |
| Q3 2019 | 5 | 0 | 0 | 4 | 0 |
| Q4 2019 | 3 | 1 | 0 | 2 | 4 |
| Q1 2020 | 1 | 0 | 0 | 4 | 1 |
| Q2 2020 | 3 | 1 | 1 | 2 | 1 |
| Q3 2020 | 12 | 2 | 3 | 0 | 3 |
| Q4 2020 | 2 | 4 | 1 | 10 | -5 |
| Q1 2021 | 39 | 8 | 3 | 0 | 1 |
| Q2 2021 | 54 | 20 | 7 | 20 | -16 |
| Q3 2021 | 18 | 28 | 25 | 15 | 1 |
| Q4 2021 | 18 | 24 | 27 | 21 | -5 |
| Q1 2022 | 9 | 16 | 34 | 19 | -4 |
| Q2 2022 | 17 | 9 | 27 | 26 | -15 |
Hedge funds changes in Atossa Therapeutics stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 0 | 0 |
|---|---|---|
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 43,000 | 0 |
| Q3 2019 | 24,000 | 0 |
| Q4 2019 | 17,000 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 78,000 | 40,000 |
| Q3 2020 | 63,000 | 33,000 |
| Q4 2020 | 91,000 | 48,000 |
| Q1 2021 | 10,219,000 | 4,572,000 |
| Q2 2021 | 84,325,000 | 71,814,000 |
| Q3 2021 | 35,030,000 | 15,560,000 |
| Q4 2021 | 8,705,000 | 5,291,000 |
| Q1 2022 | 2,464,000 | 2,869,000 |
| Q2 2022 | 1,915,000 | 2,052,000 |